Peptide Synthesis Market Forecast for 2025 and Beyond
The Peptide Synthesis Market forecast suggests significant growth driven by rising adoption of peptides in chronic disease management. With applications in oncology, metabolic disorders, and infectious diseases, peptide drugs are expected to see wider acceptance. Pharmaceutical companies are focusing on designing stable peptides with enhanced bioavailability, ensuring they can meet rising therapeutic demands.
In addition, government funding for peptide-based research and the surge in clinical trials are boosting confidence in the sector. Emerging technologies such as solid-phase peptide synthesis (SPPS) and liquid-phase synthesis are improving scalability, making peptides a viable option for large-scale drug production. By 2030, peptide-based therapeutics could represent a substantial share of the pharmaceutical pipeline, with innovative firms leading the transformation.